By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell Announces The Effective Implementation Of The Convertible Notes With Warrants (OCABSA) Financing And The Issue Of A First Tranche For An Amount Of EUR 3 Million In Nominal Value 8/3/2016 10:58:26 AM
TxCell: Financial Information For The 2nd Quarter Of 2016 7/27/2016 12:15:41 PM
TxCell Exercises Option From Weizmann Institute of Science Following Effective Grant Of Broad CAR-Treg Patent In Europe 6/22/2016 8:04:48 AM
TxCell Implements A New Financing Contract Of Up To EUR 20 Million In Nominal Value Through Convertible Notes With Warrants (OCABSA) 6/17/2016 1:52:02 PM
TxCell To Chair World’s First Workshop Dedicated To Adoptive T Cell Therapy With Regulatory T Cells 6/14/2016 12:43:56 PM
TxCell And The Lübeck Institute Of Experimental Dermatology Launch Collaboration To Develop CAR-Tregs In Bullous Pemphigoid 6/2/2016 1:40:11 PM
TxCell Presents A Series Of New Scientific Data At The ISCT 2016 Annual Meeting 5/26/2016 2:31:23 PM
TxCell Obtains Authorization From European Regulatory Authorities To Restart Ovasave Phase IIb Clinical Trial 5/25/2016 1:26:29 PM
TxCell And Ospedale San Raffaele Launch Collaboration For The Development Of CAR-Tregs In Lupus Nephritis 4/25/2016 10:11:55 AM
TxCell: Financial Information For The 1st Quarter Of 2016 4/21/2016 2:21:06 PM